Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 7 of 7 for “"CAM-DR"”.

  1. Modulation des HMG-CoA-Reduktase/GGPP/ Rho-Signalwegs zur Apoptoseinduktion in adhärenten Myelomzellen

    … Myelomzellen vermindert und somit zur „de-novo drug resistance" beiträgt. Das primäre Ziel dieser Arbeit war es, ein Zellmodell zu entwerfen, mit welchem die Untersuchung der Interaktionen von Stromazelle und Myelomzelle und damit der zelladhäsionsabhängigen Zytostatikaresistenz (CAM-DR) möglich …

    lmu-germany Repository record for Modulation des HMG-CoA-Reduktase/GGPP/ Rho-Signalwegs zur Apoptoseinduktion in adhärenten Myelomzellen (opens in a new tab)

  2. Characterization Of The Interactions Of Calmodulin With Fas And Death Receptor-5, And Determine The Role Of Calmodulin - Death Receptor-5 Binding In Disc Formation In Breast Cancer.

    … the most commonly diagnosed cancers. Calmodulin (CaM) is involved in regulating breast cancer growth, proliferation, and transformation to malignancy. CaM has been shown to play a role in regulating Fas and DR-5 mediated apoptosis. The Fas receptor apoptotic pathway has been well characterized in …

    uab Repository record for Characterization Of The Interactions Of Calmodulin With Fas And Death Receptor-5, And Determine The Role Of Calmodulin - Death Receptor-5 Binding In Disc Formation In Breast Cancer. (opens in a new tab)

  3. Synergy and Resistance Mechanisms in R115777 and PS-341 Models of Myeloma and Leukemia

    … R115777 induces apoptosis and to investigate drug resistance, we have identified and characterized a R115777-resistant human myeloma cell line. 8226/R5 cells were found to be at least 50 times more resistant to R115777 compared with the parent cell line 8226/S. 8226/R5 cells were insensitive …

    usf Repository record for Synergy and Resistance Mechanisms in R115777 and PS-341 Models of Myeloma and Leukemia (opens in a new tab)

  4. The role of integrins as a determinant of drug response and resistance

    Drug resistance continues to be one of the major obstacles to the successful treatment of hematopoietic cancers. Historically, most of the research being done in this area has been focused on reversing mechanisms of resistance which are known to be acquired by the tumor cell in vitro. Fewer studies …

    arizona-thes Repository record for The role of integrins as a determinant of drug response and resistance (opens in a new tab)

  5. Überwindung der zelladhäsionsvermittelten Chemoresistenz durch Hemmung des Mevalonat-Signalweges beim Multiplen Myelom

    … wo sie akkumulieren und durch ihr verdrägendes Wachstum zur Knochendestruktion und Beeinträchtigung der Hämatopoese führen. Die Wechselwirkung zwischen Myelomzellen und Knochenmarkmicroenvironment ist für die Pathogenese und Pathophysiologie des Multiplen Myeloms von entscheidender …

    lmu-germany Repository record for Überwindung der zelladhäsionsvermittelten Chemoresistenz durch Hemmung des Mevalonat-Signalweges beim Multiplen Myelom (opens in a new tab)

  6. NOTCH PRODUCES A DEREGULATION OF CXCR4/SDF-1A CHEMOKINE SIGNALING IN MULTIPLE MYELOMA CELLS

    … migration of MM cells, cell-adhesion-mediated drug resistance (CAM-DR) and finally bone lesions trough hyper-stimulation of osteoclasts (OCLs) activity. In our study we took advantage of a panel of MM and bone marrow stromal (BMSC) cell lines and investigated the effects of the Notch signaling …

    milano Repository record for NOTCH PRODUCES A DEREGULATION OF CXCR4/SDF-1A CHEMOKINE SIGNALING IN MULTIPLE MYELOMA CELLS (opens in a new tab)

  7. Targeting α4 Integrin Containing Complexes in Multiple Myeloma Using Peptidomimetics

    … of response to HYD1 we developed an isogenic drug resistant variant named H929-60. We show that the acquisition of resistance towards HYD1 correlates with reduced expression of the cleaved α4 integrin subunit and beta 1 integrin. Moreover, we demonstrate that HYD1 interacts with α4 integrin in …

    usf Repository record for Targeting α4 Integrin Containing Complexes in Multiple Myeloma Using Peptidomimetics (opens in a new tab)